Skip to main content
Episurf logo

Episurf — Investor Relations & Filings

Ticker · EPIS ISIN · SE0003491562 LEI · 549300GORBCSMHZB2J75 ST Manufacturing
Open in API
Filings indexed 872 across all filing types
Latest filing 2025-11-02 Board/Management Inform…
Country SE Sweden
Listing ST EPIS

About Episurf

https://episurf.com/

Episurf is a medical device company that develops and commercializes patient-specific solutions for treating painful joint injuries. The company's core technology utilizes 3D imaging to create personalized orthopedic implants and surgical instruments tailored to each patient's unique anatomy and cartilage defect. Its primary product line, the Episealer® system, provides minimally invasive implants for treating cartilage and underlying bone lesions in the knee and ankle joints. The objective of this individualized approach is to repair the joint, alleviate pain, and restore function, offering a treatment option for patients, often middle-aged, who are not yet candidates for total joint replacement surgery.

Recent filings

Filing Released Lang Actions
Board Member Resigns from the Board of Episurf Medical
Board/Management Information Classification · 1% confidence The document is a short announcement regarding the resignation of a board member (Laura Shunk) from the Board of Directors of Episurf Medical. This falls directly under the definition of an announcement of changes in the company's board of directors.
2025-11-02 English
Styrelseledamot begär utträde ur Episurf Medicals styrelse
Board/Management Information Classification · 1% confidence The document is a short announcement regarding the resignation of a board member (Laura Shunk) from the board of directors of Episurf Medical. This falls directly under the category of announcements concerning changes in the company's board of directors.
2025-11-02 Swedish
Interim / Quarterly Report 2025
Interim / Quarterly Report Classification · 1% confidence The document is a 'Delårsrapport' (Interim Report) for the period 1 January – 30 September 2025 for Episurf Medical. It contains comprehensive financial statements, management commentary, operational updates, and analysis of financial performance for the third quarter and the first nine months of the year. It meets the criteria for an Interim/Quarterly Report (IR) as it provides substantive financial data and analysis rather than just an announcement or certification. 9M 2025
2025-10-24 Swedish
Interim / Quarterly Report 2025
Interim / Quarterly Report Classification · 1% confidence The document is titled 'INTERIM REPORT 1 JANUARY – 30 SEPTEMBER 2025' and contains comprehensive financial statements, management commentary, business updates, and notes on financial position. It is clearly a quarterly/interim financial report, not an announcement or a summary, as it provides detailed financial data and analysis for the specified period. 9M 2025
2025-10-24 English
Change in number of shares and votes in Episurf Medical
Share Issue/Capital Change Classification · 1% confidence The document explicitly details a change in the total number of shares and votes resulting from a rights issue and a set-off issue. This falls directly under the category of announcements regarding new share issues or capital changes, which is defined by the code SHA.
2025-09-30 English
Förändring av antalet aktier och röster i Episurf Medical
Share Issue/Capital Change Classification · 1% confidence The document is an official announcement from Episurf Medical regarding a change in the total number of shares and votes following a rights issue and a set-off issue. This type of disclosure, specifically detailing changes in share capital and voting rights, falls under the category of share issue and capital change announcements.
2025-09-30 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.